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Glucosea b s t r a c t
Nowadays, connexin (Cx) 36 is considered the sole gap junction protein expressed in pancreatic beta
cells. In the present research we investigated the expression of Cx30.2 mRNA and protein in mouse pan-
creatic islets. Cx30.2 mRNA and protein were identiﬁed in isolated islet preparations by qRT-PCR and
Western blot, respectively. Immunohistochemical analysis showed that insulin-positive cells were
stained for Cx30.2. Confocal images from double-labeled pancreatic sections revealed that Cx30.2 and
Cx36 ﬂuorescence co-localize at junctional membranes in islets from most pancreases. Abundant
Cx30.2 tiny reactive spots were also found in cell cytoplasms. In beta cells cultured with stimulatory glu-
cose concentrations, Cx30.2 was localized in both cytoplasms and cell membranes. In addition, Cx30.2
reactivity was localized at junctional membranes of endothelial or cluster of differentiation 31 (CD31)
positive cells. Moreover, a signiﬁcant reduction of Cx30.2 mRNA was found in islets preparations incu-
bated for 24 h in 22 mM as compared with 3.3 mM glucose. Therefore, it is concluded that Cx30.2 is
expressed in beta and vascular endothelial cells of mouse pancreatic islets.
 2013 The Authors. Published by Elsevier Inc. Open access under CC BY license. 1. Introduction
Gap junctions (GJ) are conglomerates of intercellular channels.
In vertebrates they are mainly formed by a family of homologous
transmembrane proteins (20) termed connexins (Cxs). These
channels allow the direct intercellular transfer of molecules and
second messengers between adjacent cells. A connexon or hemi-
channel is an hexamer. Docking of two connexons forms an inter-
cellular channel. Since cells, from most tissues, express more than
one Cx subtype, intercellular channels may be homotypic (both
connexons formed by the same Cx subtype), heterotypic (each
connexon formed by a different Cx subtype) or heteromeric (each
connexon formed by more than one Cx). Moreover, hemichannels
at the cell membrane may be active [1]. Alterations in Cxs areinvolved in human pathology and their deﬁciency is critical for cell
development [2,3].
Diabetes is a chronic disease that involves different metabolic
disorders where subjects have in common high blood glucose lev-
els. Its world prevalence has increased around ten times in the last
4 decades [4]. Among the different hormones that regulate glucose
homeostasis, insulin is the only one that decreases glucose levels.
Insulin is produced in beta cells that, in mouse, constitute most
of the islet central mass (80%). The glucose insulin release re-
sponse curve from isolated perfused islets is well ﬁtted by a sig-
moidal function, with a threshold at 6 mM followed by a linear
increase that reaches it saturating point at 22 mM [5]. Insulin
secretion depends critically on electrical activity of beta cells in-
duced by glucose. This electrical activity consists of bursts of action
potentials which happen synchronously and in phase in most beta
cells from a single islet. This high electrical synchrony produces
cyclic changes in the interstitial [K+] and [Ca2+] [6] and in the intra-
cellular Ca2+ ([Ca2+]i) concentrations [7,8] in the different islet re-
gions. The latter determines pulses of insulin release [8–10].
Electrical coupling [11] through GJ [12] intercommunicates
most pancreatic beta cells [13,14]. Cx36 is localized at junctional
membranes of beta cells in rodent [14–17] and human islets
[18]. Isolated islets cells from Cx36-deﬁcient mice lack synchroni-
zation in their [Ca2+]i oscillations and exhibit loss of pulses of
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mice are glucose intolerant [19]. These alterations have been ex-
plained to result from beta cells uncoupling since neither GJ parti-
cles [8] nor electrical or chemical coupling [20,21] were detected in
islet cells from these animals.
From above, Cx36 is considered the only Cx expressed in beta
cells. However, besides Cx36, the mRNA of Cx43 and Cx45 have
been identiﬁed in rodent beta cells puriﬁed by cell sorting [22]
and of Cx30.3, Cx31, Cx31.1, Cx31.9, Cx37, Cx43 and Cx45 in hu-
man islets by RT-PCR [18]. However the cell-speciﬁc distribution
of most of these Cxs remains to be determined.
Moreover, we have previously proposed that GJ channels in
mouse beta cells are heteromeric [14]. This was based on the char-
acterization of the biophysical properties of the junctional currents
recorded in dual voltage clamped freshly isolated beta cell pairs
[13,14]. Intercellular channels in beta cells are weekly voltage sen-
sitive and have a tiny main unitary conductance (cj, 6 pS) [14]. In
the present research, we looked for the expression of Cx30.2 be-
cause it is the other member from the Cx family, besides Cx36,
whose biophysical properties are most compatible with those re-
corded in isolated beta cell pairs.2. Materials and methods
2.1. Animals
CD1. mice were maintained and handled in accordance with the
national and international Guiding Principles for Biomedical Re-
search Involving Animals, as promulgated by the Society for the
Study of Reproduction. Animals were anaesthetized and sacriﬁced
by decapitation before tissue dissection.
2.2. Western blot
About 500 islets were isolated from 12 pancreases and homog-
enized by sonication. Proteins were extracted using buffer (RIPA
#20–188, Millipore Corporation, Billerica, MA, USA) with protease
inhibitors (P8340, Sigma, St. Louis, MO, USA). Gels were loaded
with 50 lg of total protein. The electrophoretic run and transfer
protein protocols were performed as previously described [23].
The membranes were incubated overnight at 4 C with rabbit
anti-Cx30.2 (Invitrogen, CA, USA; 1:100). After rinsed, they were
incubated for 1 h at room temperature with a horseradish peroxi-
dase (HRP) goat secondary antibody (1:5000). Blots were revealed
with chemiluminescence (SuperSignal West Pico, Pierce, Milwau-
kee, WI, USA).
2.3. Immunohistochemistry
(IHC). Pancreases (10 mice) were ﬁxed in 4% buffered parafor-
maldehyde for 24 h. After antigens were retrieval with citrate buf-
fer and endogenous peroxidase was blocked, serial sections were
incubated with anti-Cx30.2 (1:50), anti-Cx36 (Invitrogen, CA,
USA; 1:50) or guinea pig anti-insulin (Invitrogen, CA, USA;
1:2000) for 18 h at 4 C. After rinsed, sections were incubated for
30 min at 37 C with an HRP secondary antibody (1:500), and
immunoreactivity was revealed by incubation in 3,30-diam-
inobenzidine tetrahydrochloride (Zymed, CA. USA). As negative
controls, sections were incubated only with a secondary antibody.
2.4. Immunoﬂuorescence
Pancreatic cryosections were co-incubated overnight at 4 C
with anti-Cx30.2 (1:100) and monoclonal anti-Cx36 (1:100), or
anti-cluster of differentiation 31 (CD31, BD Pharmingen, San Diego,USA; 1:500). Isolated cultured beta cells were also co-incubated
with anti-Cx30.2 and anti-insulin (1:100). After rinsed, sections
and cells were revealed with their corresponding secondary anti-
bodies. Images were acquired using a confocal laser-scanning
microscope (Olympus model FV1000, Japan). For each experimen-
tal condition, at least seven different pancreases were analyzed. As
negative controls, sections were incubated only with the corre-
sponding secondary antibody.2.5. Islets and beta cells cultures
Islets of Langerhans were dissociated from minced pancreases
using collagenase 3 mg/ml in Krebs ringer solution with 3% albu-
min, as previously described [13]. Collected islets were incubated
overnight in a DMEMmedium (GIBCO, Grand Island, NY, USA) with
11 mM D-glucose. The next day, islets were incubated for 24 h in
the DMEM containing 3.3 or 22 mM glucose. Beta cells were dis-
persed from batches of 150 islets following a protocol previously
described [13] and cultured in RPMI with 11 or 22 mM glucose
overnight before processed for immunoﬂuorescence studies. Islets
and cells were cultured at 37 C in a humidiﬁed atmosphere of 5%
CO2. All culture media were supplemented with 100 U/ml penicil-
lin, 100 lg/ml streptomycin and 10% of fetal bovine serum (FBS).2.6. RNA Isolation
Total RNA was isolated from ﬁve pools of isolated islets (450),
collected from 12 pancreases for each culture condition (3.3 or
22 mM glucose), using the RNeasy Mini kit (Qiagen, Valencia, CA,
USA), according to the manufacturer’s protocol. The quality and
purity of RNA was conﬁrmed as previously described [23]. Traces
of DNA were removed by digestion with RNase-free DNase I (Invit-
rogen, CA, USA) following the manufacture0s protocol.2.7. Real-time quantitative retrotranscription
PCR (qRT-PCR). Reverse transcription of total RNA was per-
formed as previously reported [23]. The expression of Cx30.2 and
Cx36 genes was explored in islets incubated in 3.3 or 22 mM
glucose with qRT-PCR using TaqMan probes. Glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) was used as an internal
control. TaqMan gene expression assays were used (Cx30.2,
Mm00731344_s1, Cx36 Mm00439121_m1 and GAPDH,
Mm99999915_g1; Applied Biosystems). The cDNA from ﬁve differ-
ent pools were explored in duplicates in a ﬁnal volume of 20 ll,
including 100 ng of cDNA template, 10 ll of 2X TaqMan Universal
PCR Master Mix (Applied Biosystems), 1 ll of 20X TaqMan Gene
Expression Assay, and 7 ll of RNase-free water. The cycling pro-
gram was run in a 7500 real time PCR system (Applied Biosystems,
Foster City, USA), which was set as follows: an initial PCR activa-
tion step at 50 C for 2 min followed by 95 C for 10 min, then 45
cycles of melting at 95 C for 30s and annealing/extension at
62 C for 1 min. Measurement of gene expression was based on rel-
ative standard curves constructed from a 10-fold serially diluted
pool of islets cDNAs ranging from 500 to 0.05 ng. Curves for GAPDH
gene were tested in three different experiments ran in duplicate.
The correlation coefﬁcient (r) average was higher than 0.98. The
expression of target genes was calculated based on the GAPDH
standard curve and normalized in each experiment to the intensity
of the internal reference (GADPH) using a previously described
method [29]. The normalized intensity values were measured in
ng/ll. The statistical signiﬁcance of the differences between the
groups was calculated with the t-test.
Fig. 1. Cx30.2 mRNA and protein are expressed in pancreatic islets. RT-PCR analysis of cDNA obtained from three batches of isolated islets. (A) A 84 bp band, as expected for
Cx30.2, was detected in an electrophoresis gel loaded with reactions from islets (I) and testis (T), but not in reactions in which cDNA was substituted by H2O. (B) Western blot,
where a band of 30 kDa is detected in total homogenate from total pancreas (P), islets (I) and testis (T). (C-F). Digital images of 3 lm thick pancreatic serial sections revealed
with immunoperoxidase, show that insulin positive cells (D) express Cx30.2 (C) and Cx36 (E). No reactivity was found with the secondary antibody (F).
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To address whether the Cx30.2 gene is expressed in pancreatic
islets, the mRNA expression was explored by RT-PCR and the pro-
tein by Western blot. Fig. 1A shows an electrophoretic gel where a
PCR product of the expected size (84 bp) for Cx30.2 mRNA is de-
tected in lanes loaded with reactions from mouse islets and testis
but not in reactions where H2O substituted cDNA. These last ones
were used as positive and negative controls, respectively. Cx30.2
mRNA was also identiﬁed in rat, hamster and guinea pig pancre-
ases (not shown). Fig. 1B shows an image of a Western blot where
a band of 30 kDa is identiﬁed in lanes loaded with homogenates
from total pancreas (lower panel), isolated islets (upper panel)
and testis. The latter demonstrates that the anti-Cx30.2 antibody
used recognized this Cx.
To identify the cell speciﬁc distribution of Cx30.2, IHC experi-
ments were performed in 3 lm thick serial sections of pancreases.
Figure 1 shows that cells positively stained with anti-Cx30.2 (C)
were also labeled with anti-insulin (D) and anti-Cx36 (E) which
is another beta cell marker. In contrast exocrine acinar cells were
not labeled. In addition islets from sections incubated only with
secondary antibody were not stained (F). Thus, these ﬁndings
demonstrate that Cx30.2 protein is localized in beta cells.
The subcellular distribution of Cx30.2 in beta cells was investi-
gated by immunoﬂuorescent (IF) studies. Fig. 2A–L shows confocal
images from 1 lm thick pancreatic sections from three mice,double-labeled with anti-Cx30.2 and anti-Cx36. Tiny reactive spots
of Cx30.2 were found in beta cells cytoplasms (Fig. 2A, E, J). In addi-
tion, in some islets, Cx30.2 reactive spots were also found at cell
membrane appositions (Fig. 2A), as indicated by their spatial distri-
bution close to Cx36-IF labeling (Fig. 2B). This spatial relation is
better illustrated in merge image (Fig. 2C and insert) where
Cx30.2 (green) is found adjacent to Cx36 (red). This region is also
shown at a lower ampliﬁcation (Fig. 2D, asterisk)
In other islets (5 of 7), Cx30.2 -reactive spots at cells mem-
branes (Fig. 2E) were found to have a noteworthy similar spatial
distribution to Cx36 protein (Fig. 2F). This is better illustrated in
the merge image (Fig. 2G) where Cx30.2 (green) is shown to co-
localize with Cx36 (red) at junctional membranes (yellow, arrow-
heads). This pattern is also shown at a lower (Fig. 2H) and higher
ampliﬁcation (Fig. 2I). Co-localization of Cx30.2 and Cx36 at junc-
tional membranes is also shown in beta cells from another islet
(Fig. 2J–L).
Distribution of Cx30.2 was also analyzed in beta cell cultures.
Fig. 2M–T shows confocal images of insulin positive cells (red)
from two different cell cultures incubated with 22 mM glucose.
Cx30.2 reactivity (green) was localized in the whole beta cell vol-
ume, as shown in different optical sections (Fig. 2M–P). Further-
more, in some beta cells Cx30.2-IF reactivity was higher at the
cell membrane than in the cytoplasm (Fig. 2Q–T).
High glucose concentrations increase blood ﬂow in the islet
where endothelial and beta cells are intimately associated [24].
Fig. 2. Cx30.2 is expressed in beta cell cytoplasm, junctional and non junctional membranes. (A-L) Confocal images of pancreatic sections, 1 lm thick, double-labeled, with
anti-Cx30.2 (green) and anti-Cx36 (red), where nuclei are stained with DAPI (blue). Abundant tiny Cx30.2-IF spots are found at pancreatic beta cell cytoplasm and
nonjunctional membranes from three islets (A, E, J). Moreover, in some islets, Cx30.2 (A, green) and Cx36 (B, red) reactive spots alternate at junctional membrane areas (C
arrowheads, insert, and D, asterisk). In other islets, Cx30.2 reactivity (E) is distributed at the same junctional membranes as Cx36 (F). In these areas, as shown at different
ampliﬁcations, both Cxs co-localize (G, H and I, yellow). Co-localization of both Cxs is also shown for a third islet (J-L). (M-T) Images, of 1 lm thick confocal sections, of a beta
cell clump cultured at 22 mM glucose, double-labeled with anti-Cx30.2 (green) and anti-insulin antibodies (red). Cx30.2 is localized in beta cell cytoplasm (M-P). In some beta
cells a higher density of Cx30.2 is found at the cell membranes (Q-T).
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vessels of pancreatic islets. For this, pancreatic sections were co-
incubated with anti-Cx30.2 and anti-CD31, which is a marker of
the endothelial cells membranes [25]. Confocal images shown in
Fig. 3A illustrate that cells positive for CD31 (red) and Cx30.2
(green) are localized in blood vessels distributed both at the
periphery (asterisk) and at the center (arrowheads) of pancreaticislets. At a high magniﬁcation, Cx30.2 is shown to localize in endo-
thelial cells closely associated with CD31 at junctional membranes
(Fig. 3B and C).
Cx36 mRNA has been found to decrease in rat islets maintained
under glucose stimulation for 24 h [26]. To explore whether Cx30.2
gene is also modulated by glucose its mRNA was quantiﬁed by
qRT-PCR after islets were incubated for 24 h in low (3 mM) and
Fig. 3. Cx30.2 is expressed at junctional membranes in islet vascular endothelial
cells. Confocal images of pancreatic sections of 1 lm thickness, co-incubated with
anti-Cx30.2 (green) and anti-CD31 (red), an endothelial cell marker. Cx30.2 is
expressed in central (arrowheads) and peripheral (asterisk) blood vessels (A),
localized at junctional membranes (asterisk) of endothelial cells (B-C).
776 C. Coronel-Cruz et al. / Biochemical and Biophysical Research Communications 438 (2013) 772–777high (22 mM) glucose. A signiﬁcant decrease in Cx30.2 of a 45%
(Fig. 4A) and in Cx36 of a 31% (Fig. 4B) mRNAs was found in islets
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Fig. 4. High glucose concentration downregulates Cx30.2 mRNA levels in isolated islets. Q
(3.3 mM) and high (22 mM) glucose concentrations. Transcript levels were normalized w
was found under high glucose concentration whereas Cx36 mRNA, was reduced in 31%4. Discussion
This research demonstrates that Cx30.2 is expressed in pancre-
atic islet beta cells. This conclusion is based on the detection of
Cx30.2 mRNA by qRT-PCR in rodent islet cells preparations. It is
also supported by the detection of 30 kDa-band protein in islets
homogenates. In addition, Cx30.2 protein was shown clearly local-
ized in insulin positive cells by IHC. Moreover, IF experiments re-
vealed that Cx30.2 co-localizes with Cx36 protein, which is well
known to be expressed at beta cells junctional membranes. Fur-
thermore, IF analysis in cell cultures conﬁrmed that insulin posi-
tive cells express Cx30.2.
Here, it is demonstrated by IHC studies that both Cx30.2 and
Cx36 are localized to beta cells. Moreover, by confocal images
and IF studies we documented that Cx30.2 and Cx36 co-localize
at junctional membranes of beta cells from most islets. This result
indicates that in beta cells both connexins co-exist at the same
junctional plaques.
Co-localization of Cx30.2 and Cx36 at junctional plaques is con-
sistent with the hypothesis that GJ channels in beta cells are heter-
omeric [14]. Although similar, the biophysical properties of
junctional conductance (gj) recorded in dual voltage clamped beta
cell pairs were not identical to those of Cx36 channels as recorded
in cell expression systems. Speciﬁcally, beta cell gj was not affected
with a concentration of quinine 1 mM, that is 28 times higher [14]
than the concentration found (EC50 5 lM) to close the Cx36 GJ
channels in cell expression systems [27]. Furthermore, the rela-
tionship between the normalized steady-state junctional conduc-
tance (Gss) and the transjunctional voltage applied between dual
voltage clamped isolated beta cell pairs was heterogeneous. In
55% of the cell pairs Gss was voltage insensitive, while in the
remaining 45% a symmetrical weak voltage sensitivity was found.
In the latter group of beta cell pairs, the half transjunctional volt-
age dependence (Vo = ±85) was 10 mV higher [14] than in Cx36
channels (Vo = ±75) [28,29]. Further studies are required to prove
this hypothesis. So far, both Cx30.2 [30] and Cx36 [28,29] intercel-
lular channels are known to be weakly voltage sensitive, poorly an-
ion selective and have a tiny unitary conductance (cj10 pS). Then,
differences in biophysical properties of beta cell intercellular chan-
nels with respect to those of Cx36 [13,14] may well be explained
by the co-expression of Cx36 and Cx30.2.
Confocal images showed that in some pancreatic islets Cx30.2
IF-spots were also found adjacent to Cx36 ones. This result sug-
gests that homomeric plaques formed only with Cx30.2 also exist
in islet beta cells. It also suggests that groups of Cx30.2 inter-com-
municated beta cells may be involved in the Cx36-independent
component of circulating blood insulin oscillations found in Cx36
deﬁcient mice [19]. Nonetheless, since in these mice no GJ particles
[8] or coupling [8,20,21] have been detected in islet beta cells that


























3.3 mM 22 mM
uantitative qRT-PCR analysis of Cx30.2 mRNA in islets after a 24 h incubation at low
ith respect to the constitutive gene GAPDH. A 45% decrease in the Cx30.2 (A) mRNA
(B). Data are means ± S.E.M. (P < 0.05), n = 5 pools for each experimental condition.
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on Cx36 expression.
Cx30.2 was also localized in the whole volume of beta cells, as
shown here by images from islet and cultured cells. This raises the
possibility that Cx30.2 is also expressed at non junctional cell
membranes. This is supported by the higher Cx30.2-IF reactivity
found in cell membranes compared with the one found in cyto-
plasm in some cultured beta cells (Fig. 2Q–T). It is also supported
by the abundant tiny Cx30.2-IF spots at the non junctional mem-
brane areas. Some Cxs form hemichannels, including Cx30.2 [30].
Hemichannels may be active under in vivo conditions as previously
reviewed [1]. Therefore, it is possible that Cx30.2 forms hemichan-
nels in native pancreatic beta cells. Further studies are required to
prove this hypothesis.
Here we also provide for the ﬁrst time evidence that Cx30.2 is
localized at GJ of endothelial cells of islet blood vessels. Cx30.2
has been described at junctional membranes of blood vessels of
testis [31] and retina [32]. Incubation under high glucose concen-
tration (30 mM) downregulates Cx30.2 protein in rat retinal endo-
thelial cells [32]. Therefore, the relative decrease of Cx30.2 mRNA
in islet preparations identiﬁed here by qRT-PCR may result from
its reduction in beta and/or in vascular endothelial islet cells. Fur-
ther studies are required to discern between these possibilities.
Overall, results obtained in this research demonstrate for the
ﬁrst time that Cx30.2 is expressed at junctional membranes of
endothelial and beta cells of mouse pancreatic islets. Beyond these
ﬁndings, our results demonstrate that there is an abundant expres-
sion of Cx30.2 in beta cells besides Cx36. This ﬁnding constitutes a
tipping point for the understanding of how do GJ proteins regulate
beta cell function.
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